Clinical Trial Update: Oral Topotecan With Toripalimab for Patients With Endometrial Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating oral topotecan in combination with toripalimab for endometrial cancer. The study is currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Cancer

Drugs mentioned

• Topotecan (topotecan)
• Toripalimab (Toripalimab)

Snippet

Sponsor: Fudan University | Conditions: Endometrial Cancer | Phase 2 | Status: NOT_YET_RECRUITING